http://purl.org/np/RACNyW-Z21... RACNyW-Z21

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#type type

http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement Statement

Leoni Bücken

2021-07-03T11:08:24.095Z

http://purl.org/np/RACNyW-Z21... RACNyW-Z21

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#subject subject

https://identifiers.org/drugbank:DB01367 drugbank:DB01367

Leoni Bücken

2021-07-03T11:08:24.095Z

http://purl.org/np/RACNyW-Z21... RACNyW-Z21

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/provided_by provided_by

https://w3id.org/um/NeuroDKG NeuroDKG

Leoni Bücken

2021-07-03T11:08:24.095Z

http://purl.org/np/RACNyW-Z21... RACNyW-Z21

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate predicate

https://w3id.org/biolink/vocab/treats treats

Leoni Bücken

2021-07-03T11:08:24.095Z

http://purl.org/np/RACNyW-Z21... RACNyW-Z21

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#object object

http://purl.obolibrary.org/obo/DOID_14330 DOID_14330

Leoni Bücken

2021-07-03T11:08:24.095Z

http://purl.org/np/RACNyW-Z21... RACNyW-Z21

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/relation relation

https://w3id.org/um/neurodkg/SymptomaticReliefIndication SymptomaticReliefIndication

Leoni Bücken

2021-07-03T11:08:24.095Z

http://purl.org/np/RACNyW-Z21... RACNyW-Z21

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/association_type association_type

https://w3id.org/biolink/vocab...OrPhenotypicFeatureAssociation ChemicalToDiseaseOrPhenotypicFeatureAssociation

Leoni Bücken

2021-07-03T11:08:24.095Z

http://purl.org/np/RACNyW-Z21... RACNyW-Z21

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/2000/01/rdf-schema#label label

azilect rasagiline tablets is indicated for the treatment of the signs and symptoms of idiopathic parkinson s disease as initial monotherapy and as adjunct therapy to levodopa the effectiveness of azilect was demonstrated in patients with early parkinson s disease who were receiving azilect as monotherapy and who were not receiving any concomitant dopaminergic therapy the effectiveness of azilect as adjunct therapy was demonstrated in patients with parkinson s disease who were treated with levodopa azilect is indicated for the treatment of the signs and symptoms of idiopathic parkinson s disease as initial monotherapy and as adjunct therapy to levodopa 1

Leoni Bücken

2021-07-03T11:08:24.095Z